PublicWire
Wednesday, September 24, 2014
Cellceutix Provides Update to Shareholders
Cellceutix Corporation (OTCQB: CTIX), a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications today has provided an update to its shareholders.
http://bit.ly/1ohWoTU
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment